Bitcoin surges after US and China agree on key trade issues in Kuala Lumpur talks
Key Takeaways
- China and the US reached crucial agreements on trade during Kuala Lumpur talks.
- Communication channels between both countries have improved for discussing export controls and tariff issues.
Bitcoin climbed to $113,829 on Friday morning after the US and China agreed to a framework agreement in Kuala Lumpur, resolving several key trade issues, following talks led by China’s Vice Minister of Commerce Li Chenggang.
According to US Treasury Secretary Scott Bessent, the agreement will prevent the US from imposing 100% tariffs on Chinese goods and delay new export controls on China’s rare earth minerals.
The breakthrough came after a sharp flare-up in trade tensions, as Trump’s warnings of triple-digit tariffs and Beijing’s export restrictions on rare earths rattled markets. Bitcoin briefly fell below $104,000, with the weakness spreading across digital assets.
Following Sunday’s trade news, the total crypto market cap hit $3.9 trillion, marking a 2% daily increase, according to CoinGecko’s data.
Over the last 24 hours, Bitcoin edged toward $114,000, Ethereum crossed back above $4,000, and Solana gained more than 3%.
Zcash’s ZEC, Pump.fun’s PUMP, Hyperliquid’s HYPE, and World Liberty Financial’s WLFI were among the strongest performers.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Qualcomm (QCOM.US) Snapdragon Summit Preview: 2nm Dual-Chip Debuts, AI Diversification Narrative Faces Key Verification
Qualcomm is scheduled to hold its annual Snapdragon Summit in Maui, Hawaii, from September 22 to 24 local time.
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

